Zacks Investment Management Ultragenyx Pharmaceutical Inc. Transaction History

Zacks Investment Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $825,378 - $1.12 Million	-15,026 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $137,320 - $272,946	-3,531 Reduced 19.03%	15,026 $653,000
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $1.33 Million - $1.67 Million	18,557 New	18,557 $1.42 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.37B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.